AstraZeneca
About
AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
- Cambridge,Cambridgeshire,United Kingdom
- 10001 - max
- http://www.astrazeneca.com
Details
- Last Funding Type
- IPO
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Apr 6, 1999
- Number Of Employee
- 10001 - max
- Operating Status
- Active
- Stock Symbol
- nse:ASTRAZEN
- Legal Name
- AstraZeneca PLC
AstraZeneca is global innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focus on getting the best from every medicine they make by exploring all the ways it can be used or improved.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 4, 2001 | IPO | — | — | — | — | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 8, 2022
GenAssist Therapeutics
|
Series A | — | Biotechnology | Yes |
|
Nov 29, 2022
Rgenta Therapeutics
|
Series A | $52M | Biotechnology | Yes |
|
Nov 28, 2022
ZSHK Laboratories
|
Series B | ¥90M | Yes | |
|
Aug 19, 2022
Yunjian
|
Series B | — | Biotechnology | Yes |
|
Aug 1, 2022
Doctor.One
|
Grant | €85K | Health Care | Yes |
Employee Profiles
Exits
AstraZeneca has had 9 exits. AstraZeneca most notable exits include Rani Therapeutics , ADC Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jul 30, 2021 | Rani Therapeutics | IPO | Biotechnology | Detail |
| May 14, 2020 | ADC Therapeutics | IPO | Biopharma | Detail |
| Oct 17, 2019 | Innate Pharma | IPO | Biopharma | Detail |
| Oct 2, 2019 | Viela Bio | M&A | Biopharma | Detail |
| Dec 6, 2018 | Moderna Therapeutics | IPO | Biotechnology | Detail |
Acquisition
AstraZeneca has acquired 16 organizations. Their most recent acquisition was KuDOS Pharmaceuticals Ltd on Dec 23, 2005. They acquired KuDOS Pharmaceuticals Ltd for $210M.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Dec 23, 2005
KuDOS Pharmaceuticals Ltd
|
Biotechnology | acquisition | $ 210M | Detail |
|
May 18, 2006
|
Biotechnology | acquisition | $ 567M | Detail |
|
Feb 1, 2007
Arrow Therapeutics
|
Biotechnology | acquisition | $ 150M | Detail |
|
Dec 23, 2009
Novexel
|
Biotechnology | — | — | Detail |
|
Dec 8, 2011
|
Manufacturing | acquisition | — | Detail |
